Kura Oncology names Jennifer Fulk chief financial officer
KURA•Kura Oncology appointed Jennifer Fulk chief financial officer in September 2026. Fulk most recently held senior finance and operating leadership roles at Soleno Therapeutics and previously spent over 15 years at Eli Lilly.
1. Fulk appointed CFO
Kura Oncology appointed Jennifer Fulk chief financial officer in September 2026. She most recently held senior finance and operating leadership roles at Soleno Therapeutics and previously spent over 15 years at Eli Lilly.
